Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Viral load"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 36567
Tytuł:
Evaluation of the effects of Artemisia Annua L. and Moringa Oleifera Lam. on CD4 count and viral load among PLWH on ART at Mbarara Regional Referral Hospital: a double-blind randomized controlled clinical trial.
Autorzy:
Twinomujuni SS; Department of Pharmacy, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda. .
Atukunda EC; Department of Pharmacy, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.
Mukonzo JK; Department of Pharmacology and Therapeutics, School of Biomedical Sciences, College of Health Sciences, Makerere University, P.O. Box 7062, Kampala, Uganda.
Nicholas M; Department of Pharmacy, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.
Roelofsen F; Action for Natural Medicine in the Tropics (ANAMED INTERNATIONAL), Winnenden, Germany.
Ogwang PE; Department of Pharmacy, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.
Pokaż więcej
Źródło:
AIDS research and therapy [AIDS Res Ther] 2024 Apr 16; Vol. 21 (1), pp. 22. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
HIV Infections*
Moringa oleifera*
Artemisia annua*
Anti-HIV Agents*/therapeutic use
Humans ; Viral Load ; Uganda ; Anti-Retroviral Agents/therapeutic use ; Hospitals ; CD4 Lymphocyte Count ; Referral and Consultation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania.
Autorzy:
Kahabuka MS; College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia. .; Kibong'oto National Infectious Diseases Hospital, Kilimanjaro, Tanzania. .
Woldeamanuel Y; College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Mbelele PM; Kibong'oto National Infectious Diseases Hospital, Kilimanjaro, Tanzania.
Mpolya EA; Department of Global Health and Biomedical Sciences, School of Life Sciences and Bioengineering, Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.; Institute for Health Metrics and Evaluation, Population Health Building/Hans Rosling Center, University of Washington, 3980 15th Avenue, 98195, Seattle, WA, USA.
Mpagama SG; Kibong'oto National Infectious Diseases Hospital, Kilimanjaro, Tanzania.; Department of Global Health and Biomedical Sciences, School of Life Sciences and Bioengineering, Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.
Kessy JP; Mawenzi Regional Referral Hospital, Kilimanjaro, Tanzania.
Manyazewal T; College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Apr 11; Vol. 24 (1), pp. 390. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*
Acquired Immunodeficiency Syndrome*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Female ; Adult ; Male ; Retrospective Studies ; Antiretroviral Therapy, Highly Active ; Tanzania/epidemiology ; Viral Load
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Determinants of viral load suppression failure among HIV adults on ARV attending health care facilities: a retrospective study in Tanga region, Tanzania.
Autorzy:
Mboggo E; AMREF Health Africa, Dar es Salaam, Tanzania. .
Mtisi E; Department of General Studies, Dar Es Salaam Institute of Technology, Dar es Salaam, Tanzania.
Mushy SE; Department of Community Health Nursing, Muhimbili University of Health Science, Dar es Salaam, Tanzania.
Mkawe S; AMREF Health Africa, Dar es Salaam, Tanzania.
Ngalesoni F; AMREF Health Africa, Dar es Salaam, Tanzania.
Muya A; AMREF Health Africa, Dar es Salaam, Tanzania.; Department of Community Health Nursing, Muhimbili University of Health Science, Dar es Salaam, Tanzania.
Kilimba E; AMREF Health Africa, Dar es Salaam, Tanzania.
Kamugumya D; Center for Disease Control and Prevention, Dar es salaam, Tanzania.
Mlay BS; National AIDS Control Program, Ministry of Health, Dodoma, Tanzania.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 14; Vol. 24 (1), pp. 312. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*
Adult ; Humans ; Male ; Female ; Adolescent ; Retrospective Studies ; Tanzania/epidemiology ; Viral Load ; Longitudinal Studies ; Medication Adherence ; Health Facilities
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association between Human Papillomavirus 16 Viral Load in Pregnancy and Preterm Birth.
Autorzy:
Khayargoli P; Department of Social and Preventive Medicine, Université de Montréal, Montreal, QC H3N 1X9, Canada.; Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Mayrand MH; Department of Social and Preventive Medicine, Université de Montréal, Montreal, QC H3N 1X9, Canada.; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 0A9, Canada.; Department of Obstetrics and Gynecology, Université de Montréal, Montreal, QC H3C 3J7, Canada.
Niyibizi J; Department of Social and Preventive Medicine, Université de Montréal, Montreal, QC H3N 1X9, Canada.; Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Audibert F; Department of Obstetrics and Gynecology, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Laporte L; Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Lacaille J; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 0A9, Canada.
Carceller AM; Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Lacroix J; Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Comète É; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 0A9, Canada.
Coutlée F; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Trottier H; Department of Social and Preventive Medicine, Université de Montréal, Montreal, QC H3N 1X9, Canada.; Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Pokaż więcej
Corporate Authors:
HERITAGE Study Group
Źródło:
Viruses [Viruses] 2024 Feb 15; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Premature Birth*
Papillomavirus Infections*
Infant, Newborn ; Female ; Humans ; Pregnancy ; Human papillomavirus 16/genetics ; Viral Load ; Real-Time Polymerase Chain Reaction ; DNA, Viral/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pretreatment Circulating HPV16 DNA Viral Load Predicts Risk of Distant Metastasis in Patients with HPV16-Positive Oropharyngeal Cancer.
Autorzy:
Mazurek, Agnieszka Maria (AUTHOR)
Jabłońska, Iwona (AUTHOR)
Kentnowski, Marek (AUTHOR)
Kacorzyk, Urszula (AUTHOR)
Śnietura, Mirosław (AUTHOR)
Rutkowski, Tomasz Wojciech (AUTHOR)
Pokaż więcej
Źródło:
Cancers. Mar2024, Vol. 16 Issue 6, p1163. 15p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pre-Infection Innate Immunity Attenuates SARS-CoV-2 Infection and Viral Load in iPSC-Derived Alveolar Epithelial Type 2 Cells.
Autorzy:
Kumar, Satish (AUTHOR)
Granados, Jose (AUTHOR)
Aceves, Miriam (AUTHOR)
Peralta, Juan (AUTHOR)
Leandro, Ana C. (AUTHOR)
Thomas, John (AUTHOR)
Williams-Blangero, Sarah (AUTHOR)
Curran, Joanne E. (AUTHOR)
Blangero, John (AUTHOR)
Pokaż więcej
Źródło:
Cells (2073-4409). Mar2024, Vol. 13 Issue 5, p369. 19p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial.
Autorzy:
Nichols, Russell M. (AUTHOR)
Macpherson, Lisa (AUTHOR)
Patel, Dipak R. (AUTHOR)
Yeh, Wendy W. (AUTHOR)
Peppercorn, Amanda (AUTHOR)
Pokaż więcej
Źródło:
Infectious Diseases & Therapy. Feb2024, Vol. 13 Issue 2, p401-411. 11p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Quantification of SARS‐CoV‐2 viral load in patients using time‐to‐results in antigen lateral flow tests.
Autorzy:
Braunstein, Elsa W. (AUTHOR)
Vail, Eric (AUTHOR)
Ho, David D. (AUTHOR)
Liu, Lihong (AUTHOR)
Mohri, Hiroshi (AUTHOR)
Gayhart, Matthew (AUTHOR)
Braunstein, Glenn D. (AUTHOR)
Pokaż więcej
Źródło:
CTS: Clinical & Translational Science. Feb2024, Vol. 17 Issue 2, p1-9. 9p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Temporal dynamics and drivers of durable HIV viral load suppression and persistent high‐ and low‐level viraemia during Universal Test and Treat scale‐up in Uganda: a population‐based study.
Autorzy:
Rosen, Joseph Gregory (AUTHOR)
Ssekubugu, Robert (AUTHOR)
Chang, Larry W. (AUTHOR)
Ssempijja, Victor (AUTHOR)
Galiwango, Ronald M. (AUTHOR)
Ssekasanvu, Joseph (AUTHOR)
Ndyanabo, Anthony (AUTHOR)
Kisakye, Alice (AUTHOR)
Nakigozi, Gertrude (AUTHOR)
Rucinski, Katherine B. (AUTHOR)
Patel, Eshan U. (AUTHOR)
Kennedy, Caitlin E. (AUTHOR)
Nalugoda, Fred (AUTHOR)
Kigozi, Godfrey (AUTHOR)
Ratmann, Oliver (AUTHOR)
Nelson, Lisa J. (AUTHOR)
Mills, Lisa A. (AUTHOR)
Kabatesi, Donna (AUTHOR)
Tobian, Aaron A. R. (AUTHOR)
Quinn, Thomas C. (AUTHOR)
Pokaż więcej
Źródło:
Journal of the International AIDS Society. Feb2024, Vol. 27 Issue 2, p1-14. 14p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical Relevance of Human Immunodeficiency Virus Low-level Viremia in the Dolutegravir era: Data From the Viral Load Cohort North-East Lesotho (VICONEL).
Autorzy:
Kohler, Maurus (AUTHOR)
Brown, Jennifer A (AUTHOR)
Tschumi, Nadine (AUTHOR)
Lerotholi, Malebanye (AUTHOR)
Motaboli, Lipontso (AUTHOR)
Mokete, Moliehi (AUTHOR)
Chammartin, Frédérique (AUTHOR)
Labhardt, Niklaus D (AUTHOR)
Pokaż więcej
Źródło:
Open Forum Infectious Diseases. Feb2024, Vol. 11 Issue 2, p1-7. 7p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Integrated Pest Management Strategies to Control Varroa Mites and Their Effect on Viral Loads in Honey Bee Colonies.
Autorzy:
Bubnič, Jernej (AUTHOR)
Prešern, Janez (AUTHOR)
Pietropaoli, Marco (AUTHOR)
Cersini, Antonella (AUTHOR)
Moškrič, Ajda (AUTHOR)
Formato, Giovanni (AUTHOR)
Manara, Veronica (AUTHOR)
Smodiš Škerl, Maja Ivana (AUTHOR)
Pokaż więcej
Źródło:
Insects (2075-4450). Feb2024, Vol. 15 Issue 2, p115. 14p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The association between HIV pretreatment drug resistance and virological outcomes in children and adults in sub-Saharan Africa: A systematic review and meta-analysis.
Autorzy:
Takem EN; Centers for Disease Control and Prevention (CDC), Cameroon.
Coox C; Centers for Disease Control and Prevention (CDC), Cameroon.
Shang J; Centers for Disease Control and Prevention (CDC), Cameroon.
Ndongmo C; Centers for Disease Control and Prevention (CDC), Cameroon.
Dokubo EK; Centers for Disease Control and Prevention (CDC), Cameroon.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 16; Vol. 19 (4), pp. e0300456. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV-1*
Adult ; Child ; Humans ; Anti-Retroviral Agents/therapeutic use ; Africa South of the Sahara/epidemiology ; Drug Resistance, Viral ; Viral Load
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir.
Autorzy:
Keele BF; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Okoye AA; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Fennessey CM; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Varco-Merth B; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Immonen TT; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Kose E; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Conchas A; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Pinkevych M; Infection Analytics Program, Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, Australia.
Lipkey L; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Newman L; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Macairan A; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Bosche M; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Bosche WJ; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Berkemeier B; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Fast R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Hull M; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Silipino L; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Gorelick RJ; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Duell D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Marenco A; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Brantley W; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Smedley J; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Axthelm M; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Davenport MP; Infection Analytics Program, Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, Australia.
Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2024 Apr 09; Vol. 20 (4), pp. e1012135. Date of Electronic Publication: 2024 Apr 09 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Simian Acquired Immunodeficiency Syndrome*/drug therapy
Simian Immunodeficiency Virus*/physiology
HIV Infections*/drug therapy
Animals ; Macaca mulatta ; Virus Replication ; Anti-Retroviral Agents/therapeutic use ; Anti-Retroviral Agents/pharmacology ; Viral Load
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of the COVID-19 pandemic on HIV service delivery and viral suppression: Findings from the SHARP program in Northern Nigeria.
Autorzy:
Mugo C; Kenyatta National Hospital, Nairobi, Kenya.
Adedokun O; Center for International Health, Education, and Biosecurity (CIHEB), Maryland Global Initiatives Corporation (MGIC) - University of Maryland, Abuja, Nigeria.
Alo OD; Center for International Health, Education, and Biosecurity (CIHEB), Maryland Global Initiatives Corporation (MGIC) - University of Maryland, Abuja, Nigeria.
Ezeokafor N; Center for International Health, Education, and Biosecurity (CIHEB), Maryland Global Initiatives Corporation (MGIC) - University of Maryland, Abuja, Nigeria.
Adeyemi S; Chemonics International, Abuja, Nigeria.
Kpamor Z; Chemonics International, Abuja, Nigeria.
Madueke L; Chemonics International, Abuja, Nigeria.
James E; United States Agency for International Development, Abuja, Nigeria.
Adebajo SB; Center for International Health, Education, and Biosecurity (CIHEB), Maryland Global Initiatives Corporation (MGIC) - University of Maryland, Abuja, Nigeria.
Semo BW; Chemonics International, Washington, D.C., United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 02; Vol. 19 (4), pp. e0300335. Date of Electronic Publication: 2024 Apr 02 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/epidemiology
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
Adult ; Adolescent ; Humans ; Female ; Child ; Male ; Pandemics ; Retrospective Studies ; Nigeria/epidemiology ; Cross-Sectional Studies ; Viral Load
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model.
Autorzy:
Tan B; Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Zhang X; Department Physiological Sciences, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA.
Ansari A; Center for Advanced Biotechnology and Medicine, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.; Department of Chemistry and Chemical Biology, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Jadhav P; Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Tan H; Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Li K; Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Chopra A; Center for Advanced Biotechnology and Medicine, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.; Department of Chemistry and Chemical Biology, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Ford A; Department of Veterinary Pathobiology, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA.
Chi X; Department Physiological Sciences, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA.
Ruiz FX; Center for Advanced Biotechnology and Medicine, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.; Department of Chemistry and Chemical Biology, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Arnold E; Center for Advanced Biotechnology and Medicine, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.; Department of Chemistry and Chemical Biology, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Deng X; Department Physiological Sciences, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA.; Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, OK 74078, USA.
Wang J; Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ 08854, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2024 Mar 29; Vol. 383 (6690), pp. 1434-1440. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article
MeSH Terms:
Coronavirus Papain-Like Proteases*/antagonists & inhibitors
Coronavirus Papain-Like Proteases*/chemistry
COVID-19*
SARS-CoV-2*/drug effects
SARS-CoV-2*/enzymology
Coronavirus Protease Inhibitors*/administration & dosage
Coronavirus Protease Inhibitors*/chemistry
Coronavirus Protease Inhibitors*/pharmacology
Drug Design*
COVID-19 Drug Treatment*
Animals ; Mice ; Disease Models, Animal ; Administration, Oral ; Crystallography, X-Ray ; Structure-Activity Relationship ; Viral Load/drug effects ; Male ; Mice, Inbred C57BL ; Mice, Inbred BALB C
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predictors of antiretroviral treatment failure to the first line therapy: a cross-sectional study among Iranian HIV-positive adults.
Autorzy:
Hashempour A; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Khodadad N; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ziaei R; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Rezaei B; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ghasabi F; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Falahi S; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.; Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Kenarkouhi A; Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Davarpanah MA; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. .; Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Mar 28; Vol. 24 (1), pp. 358. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*
Anti-HIV Agents*
Adult ; Humans ; Iran ; Cross-Sectional Studies ; Anti-Retroviral Agents/therapeutic use ; Anti-Retroviral Agents/pharmacology ; Treatment Failure ; Viral Load ; CD4 Lymphocyte Count ; Antiretroviral Therapy, Highly Active
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses.
Autorzy:
Nagasawa S; Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Hirata Y; Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Miyamoto S; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Ozono S; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Iida S; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Katano H; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Tsuneya S; Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kira K; Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kobayashi S; Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Nakajima M; Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Abe H; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Ikemura M; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yamamoto I; Department of Forensic Medicine, Kanagawa Dental University, Kanagawa, Japan.; Public Interest Incorporated Association Nihon Kousei-Kyoukai, Kanagawa, Japan.
Nakagawa K; Department of Forensic Medicine, Kanagawa Dental University, Kanagawa, Japan.; Public Interest Incorporated Association Nihon Kousei-Kyoukai, Kanagawa, Japan.
Kubota K; Department of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan.
Akitomi S; Japan Medical Association Research Institute, Tokyo, Japan.; International Research Institute of Disaster Science, Tohoku University, Miyagi, Japan.
Hasegawa I; Department of Forensic Medicine, Kanagawa Dental University, Kanagawa, Japan.; Public Interest Incorporated Association Nihon Kousei-Kyoukai, Kanagawa, Japan.
Ushiku T; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Suzuki T; Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Iwase H; Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Makino Y; Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Saitoh H; Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Department of Forensic Dentistry, Graduate School of Medicine and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 27; Vol. 19 (3), pp. e0287068. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
SARS-CoV-2*
COVID-19*
Humans ; RNA, Viral/genetics ; RNA, Viral/analysis ; Viral Load ; Cadaver
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.
Autorzy:
Tumwegamire A; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Fatch R; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Emenyonu NI; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Lodi S; Boston University School of Public Health, Boston, Massachusetts, United States of America.
Muyindike WR; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.; Mbarara Regional Referral Hospital, Mbarara, Uganda.
Kekibiina A; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Adong J; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Ngabirano C; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Beesiga B; Infectious Diseases Research Collaboration, Kampala, Uganda.
Marson K; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Golabi N; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Kamya M; Infectious Diseases Research Collaboration, Kampala, Uganda.
Chamie G; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Hahn JA; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 20; Vol. 19 (3), pp. e0300508. Date of Electronic Publication: 2024 Mar 20 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Alcoholism*/complications
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Male ; Humans ; Adult ; Female ; Cross-Sectional Studies ; Smoking/epidemiology ; Uganda/epidemiology ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Ethanol/therapeutic use ; Viral Load
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 36567

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies